本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.38
-0.7000-5.79%
成交量:14.75萬
成交額:168.67萬
市值:3.90億
市盈率:-12.19
高:12.12
開:12.11
低:11.08
收:12.08
52周最高:16.76
52周最低:9.85
股本:3,425.49萬
流通股本:1,792.50萬
量比:2.18
換手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-0.9338
每股收益(LYR):-1.0472
淨資產收益率:-29.58%
總資產收益率:-19.93%
市淨率:2.13
市盈率(LYR):-10.87

資料載入中...

2020/10/27

重要事件披露

8-K - Current report
2020/10/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/06

重要事件披露

8-K - Current report
2020/10/01

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/01

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/01

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/23

重要事件披露

8-K - Current report
2020/09/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/19

重要事件披露

8-K/A [Amend] - Current report
2020/08/18

重要事件披露

8-K - Current report
2020/08/14

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/06/05

重要事件披露

8-K - Current report
2020/04/15

員工持股計劃

Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/03

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]